e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.85p
   
  • Change Today:
    -1.40p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 3,758,132
  • Market Cap: £51.71m

e-Therapeutics Overview

e-Therapeutics is in the pharma and biotech sector and is currently trading at 8.85p per share. In the last year e-Therapeutics's share price has ranged from 8.13p to 23.10p.
Competitors: Verici DX , Oxford Biodynamics

Key Personnel

CEO: Ali Mortazavi
Chairman: Trevor Mervyn Jones
Non-Executive Dir: Michael Anthony Bretherton

Contact Details

Address: 17 Blenheim Office Park, Long Hanborough, United Kingdom, OX29 8LN
Phone: +44 (0) 191 233 1317
Fax: +44 (0) 191 233 1303
Website: http://www.etherapeutics.co.uk/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B2823H99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 8.85p
Change Today -1.40p
% Change -13.66 %
52 Week High 23.10
52 Week Low 8.13
Volume 3,758,132
Shares Issued 584.34m
Market Cap £51.71m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.76% below the market average18.76% below the market average18.76% below the market average18.76% below the market average18.76% below the market average
50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average
Price Trend
67.43% below the market average67.43% below the market average67.43% below the market average67.43% below the market average67.43% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income Not Available
Growth
15.26% below the market average15.26% below the market average15.26% below the market average15.26% below the market average15.26% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
08:49 688,226 @ 8.55p
16:30 12,437 @ 8.66p
16:15 15,496 @ 9.00p
16:15 41,021 @ 9.00p
16:15 13,021 @ 9.00p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page